A Multicenter, Randomized, Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Analgesic Effect of the INL-001 Bupivacaine HCl Collagen Implant in Children 2 to <17 Years of Age Following Open Inguinal Hernia Repair

Trial Profile

A Multicenter, Randomized, Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Analgesic Effect of the INL-001 Bupivacaine HCl Collagen Implant in Children 2 to <17 Years of Age Following Open Inguinal Hernia Repair

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 04 Sep 2017

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions; Registrational
  • Sponsors Innocoll
  • Most Recent Events

    • 31 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top